NIH Weekly Funding Opportunities and Policy Notices

Wednesday, February 8, 2017 - 6:35am
Funding Opportunity PAR-17-158 from the NIH Guide for Grants and Contracts. This FOA seeks applications which propose secondary analyses of existing clinical research datasets to investigate constructs identified in the NIMH's Research Domain Criteria (RDoC) initiative and to test novel hypotheses using the RDoC framework.
Tuesday, February 7, 2017 - 8:39am
Funding Opportunity RFA-FD-17-004 from the NIH Guide for Grants and Contracts. This program expansion FOA provides a mechanism for organizations receiving only competition A funding under PAR-16-137 to apply for competition B funding. Only those states/territories currently receiving funding for competition A under PAR-16-137 are eligible to apply.
Monday, February 6, 2017 - 10:41am
Notice NOT-NS-17-016 from the NIH Guide for Grants and Contracts
Monday, February 6, 2017 - 9:23am
Notice NOT-OD-17-041 from the NIH Guide for Grants and Contracts
Monday, February 6, 2017 - 8:30am
Notice NOT-HL-17-486 from the NIH Guide for Grants and Contracts
Monday, February 6, 2017 - 8:27am
Notice NOT-CA-17-023 from the NIH Guide for Grants and Contracts
Monday, February 6, 2017 - 8:22am
Notice NOT-AI-17-012 from the NIH Guide for Grants and Contracts
Monday, February 6, 2017 - 8:18am
Notice NOT-CA-17-026 from the NIH Guide for Grants and Contracts
Friday, February 3, 2017 - 9:12am
Funding Opportunity PAR-17-153 from the NIH Guide for Grants and Contracts. The "epitranscriptome" refers to chemical modifications of RNA molecules. RNA modifications in the brain have been reported to regulate the fate and function of both coding and noncoding RNAs and are emerging as a critical element of cellular function. The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and/or the associated modification proteins that act on RNA (readers, writers, and erasers) and play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders.
Friday, February 3, 2017 - 9:12am
Funding Opportunity PAR-17-152 from the NIH Guide for Grants and Contracts. The "epitranscriptome" refers to chemical modifications of RNA molecules. RNA modifications in the brain have been reported to regulate the fate and function of both coding and noncoding RNAs and are emerging as a critical element of cellular function. The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and in the associated modification proteins that act on RNA (readers, writers, and erasers) that play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders.
Friday, February 3, 2017 - 8:37am
Funding Opportunity PAR-17-154 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens collected as part of a previous cooperative agreement award from NIDCR.

Pages